Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2.

Neuro Oncol 2013 Aug 14;15(8):972-8. Epub 2013 Jul 14.

Department of Radiation Oncology, Dana-Farber/Brigham and Women’s Cancer Center, Harvard Medical School, Boston, MA, USA.

The traditional clinical trials infrastructure may not be ideally suited to evaluate the numerous therapeutic hypotheses that result from the increasing number of available targeted agents combined with the various methodologies to molecularly subclassify patients with glioblastoma. Additionally, results from smaller screening studies are rarely translated to successful larger confirmatory studies, potentially related to a lack of efficient control arms or the use of unvalidated surrogate endpoints. Streamlining clinical trials and providing a flexible infrastructure for biomarker development is clearly needed for patients with glioblastoma. The experience developing and implementing the I-SPY studies in breast cancer may serve as a guide to developing such trials in neuro-oncology.

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/not088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714161PMC
August 2013
11 Reads

Publication Analysis

Top Keywords

patients glioblastoma
8
clinical trials
8
efficient control
4
lack efficient
4
studies lack
4
control arms
4
arms unvalidated
4
endpoints streamlining
4
surrogate endpoints
4
unvalidated surrogate
4
confirmatory studies
4
successful larger
4
additionally smaller
4
glioblastoma additionally
4
subclassify patients
4
molecularly subclassify
4
smaller screening
4
screening studies
4
streamlining clinical
4
translated successful
4

References

(Supplied by CrossRef)

McLendon et al.
Nature; Physical Science (London) 2008

Science 2008

2011

Zia et al.
Journal of Clinical Oncology 2005

Journal of Clinical Oncology 2011

Barker et al.
Clinical pharmacology and therapeutics 2009

Meurer et al.
Annals of emergency medicine 2012

CANCER DISC 2011

Berry et al.
Clinical Cancer Research 2012

Galanis et al.
The lancet oncology 2012

Clinical Cancer Research 2010

Similar Publications